| 06/26/2026 12:40 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/23/2026 2:26 PM | Eli Lilly and Company (59478) Filer | Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
| 06/16/2026 3:13 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2026 3:14 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 10:03 AM | Eli Lilly and Company (59478) Subject Yuffa Ilya (1826001) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/02/2026 8:16 AM | Eli Lilly and Company (59478) Subject NEW YORK STOCK EXCHANGE LLC (876661) Filed by | Form 25-NSE | |
| 05/28/2026 2:02 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/22/2026 1:05 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/20/2026 3:30 PM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/20/2026 3:22 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/19/2026 3:16 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for LLY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Eli Lilly and Company and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/19/2026 3:17 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/19/2026 3:18 PM | Eli Lilly and Company (59478) Issuer LUCIANO JUAN R (1455792) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/19/2026 3:19 PM | Eli Lilly and Company (59478) Issuer Sulzberger Gabrielle (1262388) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/08/2026 5:05 AM | Eli Lilly and Company (59478) Filer | Form 424B2 Transaction specifc information for a delayed shelf offering | |
| 05/07/2026 3:41 PM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2026 4:25 PM | Eli Lilly and Company (59478) Subject | Form FWP | |
| 05/06/2026 3:35 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/06/2026 7:04 AM | Eli Lilly and Company (59478) Filer | Form 424B2 Transaction specifc information for a delayed shelf offering | |
| 04/30/2026 10:25 AM | Eli Lilly and Company (59478) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/30/2026 6:03 AM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/29/2026 12:18 PM | Eli Lilly and Company (59478) Subject Friends Fiduciary Corp (1696940) Filed by | Form PX14A6G | |
| 04/21/2026 3:14 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 3:16 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 3:18 PM | Eli Lilly and Company (59478) Issuer LUCIANO JUAN R (1455792) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 3:20 PM | Eli Lilly and Company (59478) Issuer Sulzberger Gabrielle (1262388) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 2:25 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Filed by | Form SCHEDULE 13G/A | |
| 03/31/2026 7:18 AM | Centessa Pharmaceuticals plc (1847903) Subject Eli Lilly and Company (59478) Filed by | Form DFAN14A | |
| 03/26/2026 5:02 PM | Eli Lilly and Company (59478) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/20/2026 3:23 PM | Eli Lilly and Company (59478) Filer | Form DEFA14A | |
| 03/17/2026 3:29 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/17/2026 3:30 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:35 PM | Eli Lilly and Company (59478) Filer | Form PRE 14A | |
| 02/19/2026 3:18 PM | Dozier Eric (1955972) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/12/2026 3:22 PM | Eli Lilly and Company (59478) Issuer Rau Diogo (1860253) Reporting | Form 4/A | |
| 02/12/2026 12:58 PM | Eli Lilly and Company (59478) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/11/2026 3:14 PM | Custer Kenneth L. (2071542) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 3:16 PM | Dozier Eric (1955972) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 3:17 PM | Eli Lilly and Company (59478) Issuer Hakim Anat (1685556) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 3:17 PM | Eli Lilly and Company (59478) Issuer Hernandez Edgardo (1861052) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 3:19 PM | Eli Lilly and Company (59478) Issuer Jonsson Patrik (1786054) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Your book attached (Ad) Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link.
He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. Download the Safe Trade Options Formula book for free before access closes |
| 02/11/2026 3:20 PM | Eli Lilly and Company (59478) Issuer Montarce Lucas (1752447) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 3:22 PM | Eli Lilly and Company (59478) Issuer Rau Diogo (1860253) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 6:05 AM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/23/2026 8:27 AM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Filed by | Form SCHEDULE 13G/A | |
| 01/21/2026 3:25 PM | Eli Lilly and Company (59478) Issuer LUCIANO JUAN R (1455792) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 3:27 PM | Eli Lilly and Company (59478) Issuer Sulzberger Gabrielle (1262388) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/15/2026 5:01 AM | Aktis Oncology, Inc. (2035832) Issuer Eli Lilly and Company (59478) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/15/2026 5:02 AM | Aktis Oncology, Inc. (2035832) Subject Eli Lilly and Company (59478) Filed by | Form SCHEDULE 13D | |
| 12/23/2025 11:52 AM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 3:41 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 3:42 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 3:43 PM | Eli Lilly and Company (59478) Issuer Hedley Mary Lynne (1340823) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 3:45 PM | Eli Lilly and Company (59478) Issuer LUCIANO JUAN R (1455792) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 3:46 PM | Eli Lilly and Company (59478) Issuer Sulzberger Gabrielle (1262388) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/09/2025 7:46 AM | Adverum Biotechnologies, Inc. (1501756) Subject Eli Lilly and Company (59478) Filed by | Form SC TO-T/A | |
| 12/08/2025 3:10 PM | Bertozzi Carolyn R (1698766) Reporting Eli Lilly and Company (59478) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 11/24/2025 2:01 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/21/2025 3:19 PM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/20/2025 3:00 PM | Eli Lilly and Company (59478) Issuer LILLY ENDOWMENT INC (316011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/19/2025 3:00 PM | Eli Lilly and Company (59478) Issuer LILLY ENDOWMENT INC (316011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/19/2025 2:05 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/18/2025 3:39 PM | Eli Lilly and Company (59478) Issuer JOHNSON KIMBERLY H (1658089) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/18/2025 3:25 PM | Eli Lilly and Company (59478) Issuer Moeller Jon R (1450613) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/18/2025 3:26 PM | Eli Lilly and Company (59478) Issuer Sulzberger Gabrielle (1262388) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/18/2025 3:17 PM | Eli Lilly and Company (59478) Issuer Hedley Mary Lynne (1340823) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/18/2025 3:19 PM | Eli Lilly and Company (59478) Issuer JACKSON JAMERE (1601813) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/18/2025 3:21 PM | Eli Lilly and Company (59478) Issuer Kaelin William G Jr (1551715) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/18/2025 3:12 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 3:00 PM | Eli Lilly and Company (59478) Issuer LILLY ENDOWMENT INC (316011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2025 3:00 PM | Eli Lilly and Company (59478) Issuer LILLY ENDOWMENT INC (316011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2025 2:02 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/12/2025 2:15 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/10/2025 5:00 PM | Eli Lilly and Company (59478) Issuer Skovronsky Daniel (1741474) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/10/2025 5:01 PM | Eli Lilly and Company (59478) Issuer Ricks David A (1538604) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/10/2025 2:11 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/04/2025 3:00 PM | Eli Lilly and Company (59478) Issuer LILLY ENDOWMENT INC (316011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/04/2025 2:05 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/03/2025 2:06 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/30/2025 4:34 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Filed by | Form SCHEDULE 13G/A | |
| 10/30/2025 1:54 PM | Eli Lilly and Company (59478) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 10/30/2025 10:15 AM | Eli Lilly and Company (59478) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/30/2025 6:03 AM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/24/2025 3:30 PM | Adverum Biotechnologies, Inc. (1501756) Subject Eli Lilly and Company (59478) Filed by | Form SC TO-C | |
| 10/22/2025 3:17 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2025 3:19 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2025 3:22 PM | Eli Lilly and Company (59478) Issuer Hedley Mary Lynne (1340823) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2025 3:24 PM | Eli Lilly and Company (59478) Issuer LUCIANO JUAN R (1455792) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2025 3:24 PM | Eli Lilly and Company (59478) Issuer Sulzberger Gabrielle (1262388) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/14/2025 3:00 PM | Eli Lilly and Company (59478) Issuer LILLY ENDOWMENT INC (316011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/10/2025 3:00 PM | Eli Lilly and Company (59478) Issuer LILLY ENDOWMENT INC (316011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Do NOT Buy SpaceX – Do This Instead (Ad) SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors.
Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now. Read Tilson's free analysis and find out what to do with your money |
| 10/10/2025 1:57 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/09/2025 3:00 PM | Eli Lilly and Company (59478) Issuer LILLY ENDOWMENT INC (316011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/08/2025 3:00 PM | Eli Lilly and Company (59478) Issuer LILLY ENDOWMENT INC (316011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/07/2025 3:00 PM | Eli Lilly and Company (59478) Issuer LILLY ENDOWMENT INC (316011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/06/2025 3:00 PM | Eli Lilly and Company (59478) Issuer LILLY ENDOWMENT INC (316011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/06/2025 2:35 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/02/2025 2:20 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/01/2025 3:08 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/19/2025 3:00 PM | Eli Lilly and Company (59478) Issuer LILLY ENDOWMENT INC (316011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |